Using in vitro and in vivo screens to identify essential RUNX1/ETO transcriptional targets in AML, Martinez-Soria identify CCND2 as required for leukemia maintenance and self-renewal. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.